Skip to content

Study for Grain Moxibustion in the Treatment of Cancer-Related Fatigue

Study for Grain Moxibustion in the Treatment of Cancer-Related Fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020874
Enrollment
Unknown
Registered
2019-01-21
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-Related Fatigue

Interventions

Group A:Three 'zhuangs' of Grain moxibustion
Group B:Six 'zhuangs' of Grain moxibustion
Group C:Nine 'zhuangs' of Grain moxibustion
Control group:Symptomatic treatment and nutritional support

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients with lung cancer, gastric cancer, breast cancer, lung cancer and cervical cancer diagnosed by histopathology or cytology received adjuvant radiotherapy and chemotherapy. The KPS scores were more than 60; the estimated survival time was more than 6 months; all the examination indexes were in accordance with the indications of chemotherapy and moxibustion. The compliance was good and could understand the situation of this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: No definite tumor focus (including measurable and unmeasurable); other treatments similar to this study may affect the effect indicators of this study; Severe cardiovascular and cerebrovascular diseases, diabetes, or mental disorders; existing severe acute infections, and not controlled, or suppurative and chronic infections; poor compliance; not suitable for moxibustion, direct moxibustion and allergic to moxa.

Design outcomes

Secondary

MeasureTime frame
Tumor size;weight;Physical condition;

Primary

MeasureTime frame
Fatigue degree;Quality of life;

Countries

China

Contacts

Public ContactTianshu Xu

Nanjing Drum Tower Hospital

tianshuxu2007@126.com+86 025 83304616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026